Global Patent Index - EP 1605935 A2

EP 1605935 A2 20051221 - METHODS OF USING AND COMPOSITIONS COMPRISING SELECTIVE CYTOKINE INHIBITORY DRUGS FOR THE TREATMENT AND MANAGEMENT OF DISORDERS OF THE CENTRAL NERVOUS SYSTEM

Title (en)

METHODS OF USING AND COMPOSITIONS COMPRISING SELECTIVE CYTOKINE INHIBITORY DRUGS FOR THE TREATMENT AND MANAGEMENT OF DISORDERS OF THE CENTRAL NERVOUS SYSTEM

Title (de)

VERFAHREN ZUR VERWENDUNG VON UND ZUSAMMENSETZUNGEN MIT SELEKTIVEN ZYOTKIN-HEMMENDEN ARZNEIMITTELN ZUR BEHANDLUNG UND VERSORGUNG VON ERKRANKUNGEN DES ZENTRALEN NERVENSYSTEMS

Title (fr)

METHODES D'UTILISATION ET COMPOSITIONS COMPRENANT DES MEDICAMENTS SELECTIFS INHIBITOIRES DE CYTOKINE POUR LE TRAITEMENT ET POUR LA GESTION DE TROUBLES DU SYSTEME NERVEUX CENTRAL

Publication

EP 1605935 A2 20051221 (EN)

Application

EP 04717992 A 20040305

Priority

  • US 2004006782 W 20040305
  • US 45237403 P 20030306

Abstract (en)

[origin: WO2004080393A2] Methods of treating, preventing and/or managing central nervous system disorders, such as Parkinson disease, Alzheimer disease, mild cognitive impairment, Huntington disease, Amytophic Lateral Sclerosis, depression and defective long-term memory, and related syndromes are disclosed. Specific methods encompass the administration of a selective cytokine inhibitory drug, or a pharmaceutically acceptable salt, solvate, hydrate, stereoisomer, clathrate, or prodrug thereof, alone or in combination with a second active ingredient. Pharmaceutical compositions, single unit dosage forms, and kits suitable for use in methods of the invention are also disclosed.

IPC 1-7

A61K 31/4035

IPC 8 full level

A61K 31/553 (2006.01); A61K 31/554 (2006.01); A61K 45/06 (2006.01)

CPC (source: EP KR)

A61K 31/4035 (2013.01 - KR); A61K 31/553 (2013.01 - EP); A61K 31/554 (2013.01 - EP); A61K 45/06 (2013.01 - EP); A61P 1/08 (2017.12 - EP); A61P 25/00 (2017.12 - EP); A61P 25/08 (2017.12 - EP); A61P 25/14 (2017.12 - EP); A61P 25/16 (2017.12 - EP); A61P 25/20 (2017.12 - EP); A61P 25/24 (2017.12 - EP); A61P 25/28 (2017.12 - EP); A61P 29/00 (2017.12 - EP); A61P 43/00 (2017.12 - EP)

Designated contracting state (EPC)

AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR

DOCDB simple family (publication)

WO 2004080393 A2 20040923; WO 2004080393 A3 20041202; AU 2004220607 A1 20040923; AU 2004220607 B2 20090611; BR PI0408113 A 20060301; CA 2517845 A1 20040923; CN 1780616 A 20060531; CN 1780616 B 20100512; EP 1605935 A2 20051221; EP 1605935 A4 20090520; IL 170710 A0 20110801; JP 2006519875 A 20060831; KR 100831545 B1 20080521; KR 20050109971 A 20051122; MX PA05009435 A 20051123; NZ 542408 A 20090331; ZA 200507322 B 20070328

DOCDB simple family (application)

US 2004006782 W 20040305; AU 2004220607 A 20040305; BR PI0408113 A 20040305; CA 2517845 A 20040305; CN 200480011819 A 20040305; EP 04717992 A 20040305; IL 17071005 A 20050906; JP 2006509174 A 20040305; KR 20057016598 A 20050906; MX PA05009435 A 20040305; NZ 54240804 A 20040305; ZA 200507322 A 20040305